Adenosine dose should be less when administered through a central line

被引:5
作者
Chang, M [1 ]
Wrenn, K [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Med Ctr, Dept Emergency Med, Nashville, TN 37232 USA
关键词
adenosine; paroxysmal supraventricular tachycardia;
D O I
10.1016/S0736-4679(01)00464-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A patient with a port-a-cath was given 12 mg of adenosine for paroxysmal supraventricular tachycardia (PSVT), resulting in prolonged (13 s) bradycardia and severe side effects. When the same patient presented 2 weeks later for recurrent PSVT, only 3 mg of adenosine was needed to terminate the episode, without the patient experiencing prolonged bradycardia or severe side effects. The literature suggests that for patients with central venous catheters, a lower dose of adenosine should be used to terminate PSVT. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 14 条
[1]   THE CARDIAC EFFECTS OF ADENOSINE [J].
BELARDINELLI, L ;
LINDEN, J ;
BERNE, RM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1989, 32 (01) :73-97
[2]   CARDIOVASCULAR AND RESPIRATORY EFFECTS OF ADENOSINE IN CONSCIOUS MAN - EVIDENCE FOR CHEMORECEPTOR ACTIVATION [J].
BIAGGIONI, I ;
OLAFSSON, B ;
ROBERTSON, RM ;
HOLLISTER, AS ;
ROBERTSON, D .
CIRCULATION RESEARCH, 1987, 61 (06) :779-786
[3]   Adenosine- and adenine-nucleotide-mediated inhibition of normal and transformed keratinocyte proliferation is dependent upon dipyridamole-sensitive adenosine transport [J].
Brown, JR ;
Cornell, K ;
Cook, PW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (05) :849-859
[4]  
CASS CE, 1987, ADENOSINE TRANSPORT, P13
[5]   Antiarrhythmic agents and proarrhythmia [J].
Chaudhry, GM ;
Haffajee, CI .
CRITICAL CARE MEDICINE, 2000, 28 (10) :N158-N164
[6]   DIAGNOSTIC AND THERAPEUTIC USE OF ADENOSINE IN PATIENTS WITH SUPRAVENTRICULAR TACHYARRHYTHMIAS [J].
DIMARCO, JP ;
SELLERS, TD ;
LERMAN, BB ;
GREENBERG, ML ;
BERNE, RM ;
BELARDINELLI, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :417-425
[7]   ADENOSINE - ELECTROPHYSIOLOGIC EFFECTS AND THERAPEUTIC USE FOR TERMINATING PAROXYSMAL SUPRA-VENTRICULAR TACHYCARDIA [J].
DIMARCO, JP ;
SELLERS, TD ;
BERNE, RM ;
WEST, GA ;
BELARDINELLI, L .
CIRCULATION, 1983, 68 (06) :1254-1263
[8]   ADENOSINE FOR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA - DOSE RANGING AND COMPARISON WITH VERAPAMIL - ASSESSMENT IN PLACEBO-CONTROLLED, MULTICENTER TRIALS [J].
DIMARCO, JP ;
MILES, W ;
AKHTAR, M ;
MILSTEIN, S ;
SHARMA, AD ;
PLATIA, E ;
MCGOVERN, B ;
SCHEINMAN, MM ;
GOVIER, WC .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (02) :104-110
[9]   DIPYRIDAMOLE INHIBITION OF ADENOSINE METABOLISM IN HUMAN-BLOOD [J].
KLABUNDE, RE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 93 (1-2) :21-26
[10]   SAFETY AND EFFICACY OF CENTRAL INTRAVENOUS BOLUS ADMINISTRATION OF ADENOSINE FOR TERMINATION OF SUPRAVENTRICULAR TACHYCARDIA [J].
MCINTOSHYELLIN, NL ;
DREW, BJ ;
SCHEINMAN, MM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (03) :741-745